NabGen, Inc.
NabGen is dedicated to developing clinically meaningful antibody suppression to enable effective gene therapies. Their mission is to bring the promise of gene therapy to every patient and make it last by overcoming the body's own defenses that block these treatments. They focus on creating therapeutics that transiently and safely suppress all antibodies, unlocking the full potential of cutting-edge treatments for patients with rare diseases.
Industries
Nr. of Employees
small (1-50)
NabGen, Inc.
Products
Neutralizing antibody suppression therapeutic platform
A therapeutic platform designed to transiently and safely suppress neutralizing antibodies to enable administration or redosing of gene therapies; engineered for adjustable duration of action, vector-agnostic compatibility, and clinical/manufacturing readiness.
Neutralizing antibody suppression therapeutic platform
A therapeutic platform designed to transiently and safely suppress neutralizing antibodies to enable administration or redosing of gene therapies; engineered for adjustable duration of action, vector-agnostic compatibility, and clinical/manufacturing readiness.
Services
Collaborations and partnerships to apply antibody-suppression technology in preclinical and translational programs supporting gene therapy enablement.
Collaborations and partnerships to apply antibody-suppression technology in preclinical and translational programs supporting gene therapy enablement.
Expertise Areas
- Antibody suppression therapeutics
- Gene therapy enablement
- Biologic formulation and delivery
- Preclinical translational development
Key Technologies
- Antibody suppression platform
- Vector-agnostic therapeutic design
- Biologic formulation technologies
- Neutralizing antibody assays